Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction
SWEDES
Very Early Initiation of Treatment With Thrombolysis and Low Molecular Weight Heparin, Versus Abciximab and Low Molecular Weight Heparin Followed by Percutaneous Coronary Intervention, for Acute ST-Elevation Myocardial Infarction
1 other identifier
interventional
205
1 country
5
Brief Summary
The main objective is to compare a fibrinolytic strategy with an interventional strategy initiated as early as possible, preferably in the pre-hospital phase, with respect to resolution of ST-segment elevation at 120 minutes after inclusion and Thrombolysis In Myocardial Infarction (TIMI) flow grade evaluated at a mandated coronary angiography 5 to 7 days after inclusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Nov 2001
Typical duration for phase_4
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
November 7, 2008
CompletedFirst Posted
Study publicly available on registry
December 10, 2008
CompletedResults Posted
Study results publicly available
December 10, 2008
CompletedDecember 10, 2008
November 1, 2008
1.6 years
November 7, 2008
November 7, 2008
December 2, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Patients With ST-segment Elevation Resolution Equal or More Than 50%
ST-segment elevation resolution was measured in the lead with most prominent ST elevation at time of inclusion
120 minutes after inclusion
Number of Patients With Thrombolysis In Myocardial Infarction (TIMI) Flow Grade 3
Thrombolysis In Myocardial Infarction (TIMI) flow grade in the infarct related artery 5-7 days after inclusion.
5-7 days after inclusion
Secondary Outcomes (3)
Death
30 days
Reinfarction
30 days
Stroke
30 days
Study Arms (2)
thrombolysis
ACTIVE COMPARATORinvasive
ACTIVE COMPARATORInterventions
comparison to thrombolysis
Eligibility Criteria
You may qualify if:
- Patients presenting within 6 h after onset of chest pain lasting for more than 30 min and with significant ST-segment elevation on ECG.
You may not qualify if:
- BP \>180/110
- Known bleeding disorder
- Cardiogenic shock
- CPR\>10 min
- Ongoing anticoagulant therapy
- Renal insufficiency
- Weight \>120 kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sahlgrenska University Hospitallead
- Stockholm South General Hospitalcollaborator
- Region Örebro Countycollaborator
- Norra Alvsborgs Lans Hospital, Trollhattancollaborator
- Varberg Hospital, Swedencollaborator
Study Sites (5)
Sahlgrenska University Hospital
Gothenburg, Sweden
Orebro University Hospital
Örebro, Sweden
Sodersjukhuset
Stockholm, Sweden
Norra Alvsborgs lans Hospital
Trollhättan, Sweden
Varberg Hospital
Varberg, Sweden
Related Publications (3)
Svensson L, Aasa M, Dellborg M, Gibson CM, Kirtane A, Herlitz J, Ohlsson A, Karlsson T, Grip L. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006 Apr;151(4):798.e1-7. doi: 10.1016/j.ahj.2005.09.013.
PMID: 16569536RESULTAasa M, Kirtane AJ, Dellborg M, Gibson MC, Prahl-Abrahamsson U, Svensson L, Grip L. Temporal changes in TIMI myocardial perfusion grade in relation to epicardial flow, ST-resolution and left ventricular function after primary percutaneous coronary intervention. Coron Artery Dis. 2007 Nov;18(7):513-8. doi: 10.1097/MCA.0b013e3282c1fdb6.
PMID: 17925603RESULTAasa M, Henriksson M, Dellborg M, Grip L, Herlitz J, Levin LA, Svensson L, Janzon M. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial. Am Heart J. 2010 Aug;160(2):322-8. doi: 10.1016/j.ahj.2010.05.008.
PMID: 20691839DERIVED
MeSH Terms
Interventions
Results Point of Contact
- Title
- Lars Grip
- Organization
- Sahlgren's University Hospital/S, Gothenburg
Study Officials
- PRINCIPAL INVESTIGATOR
Lars Grip, M.D. PhD
Sahlgren's University Hospital/S
- STUDY CHAIR
Leif Svensson, M.D. PhD
Stockholm South General Hospital
- STUDY CHAIR
Johan Herlitz, M.D. PhD
Sahlgren's University Hospital/S
- STUDY CHAIR
Mikael Dellborg, M.D. PhD
Sahlgren's University Hospital/O
- STUDY CHAIR
Ake Ohlsson, M.D. PhD
Stockholm South General Hospital
- STUDY CHAIR
Mikael Aasa, M.D.
Stockholm South General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 7, 2008
First Posted
December 10, 2008
Study Start
November 1, 2001
Primary Completion
June 1, 2003
Study Completion
June 1, 2004
Last Updated
December 10, 2008
Results First Posted
December 10, 2008
Record last verified: 2008-11